Delivery Order SPE2DB20D3111-SPE2DB25FA7LY
Award Date
4/22/25
Potential Completion Date
4/23/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,491.83 firm fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Pen, 3mL, a diabetes medication. The contract has an ultimate completion date of April 18, 2025 and is not set aside for any special type of business. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award, with ID SPE2DB20D1047|SPE2DB24FF30G, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,312.13 fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Pen 3mL, with a completion date of November 30, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,212.02 firm-fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Pen 3mL, with a performance period ending on April 10, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a broad...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,393.62, is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL. The award has an ultimate completion date of April 30, 2024 and is a Firm Fixed Price Delivery Order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award, with ID SPE2DB22D3016|SPE2DB24FAYH8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,027.85, is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL, a critical medical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 14, 2024. It is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,791.16 firm-fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Pen 3mL, a diabetes medication. The contract has an ultimate completion date of July 26, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,024.94 firm fixed-price delivery order is for the supply of 4562705571 - Insulin Aspart 100 Unit/Ml Pen 3Ml. The award has an ultimate completion date of November 6, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,597.35, is for the delivery of insulin aspart 100 unit/ml pen 3ml to support military healthcare programs. It is a Firm Fixed Price delivery order with an ultimate completion date of October 26, 2023. The contract is not designated under any set-aside requirements,...
This federal contract award, with ID SPE2DX15D2204|SPE2DX24F70DF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4563304162 Insulin Aspart 100 Unit/mL Pen 3mL, with an ultimate completion date of January 12, 2024 and a ceiling value of $10,043.18. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,845.94 firm fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Pen 3mL, a critical medication for diabetes management. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued...